Moshe Talpaz

Person

Ann Arbor, MI, US

People

Patents Grantslast 30 patents

Information Patent Grant
Deubiquitinase inhibitors and methods for use of the same
- Patent number 9,868,736
- Issue date Jan 16, 2018
- The Regents of the University of Michigan
- Nicholas J. Donato
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for treatment of cell proliferative diseases
- Patent number 9,096,499
- Issue date Aug 4, 2015
- Board of Regents, The University of Texas System
- Waldemar Priebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Deubiquitinase inhibitors and methods for use of the same
- Patent number 8,809,377
- Issue date Aug 19, 2014
- The Regents of the University of Michigan
- Nicholas J. Donato
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for treatment of cell proliferative diseases
- Patent number 8,648,102
- Issue date Feb 11, 2014
- Board of Regents, The University of Texas System
- Waldemar Priebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of c-Src inhibitors alone or in combination with STI571 for the...
- Patent number 8,268,837
- Issue date Sep 18, 2012
- Novartis AG
- Nicholas J Donato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for treatment of cell proliferative diseases
- Patent number 8,119,827
- Issue date Feb 21, 2012
- Board of Regents, The University of Texas System
- Waldemar Priebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of c-Src inhibitors alone or in combination with STI571 for the...
- Patent number 8,119,649
- Issue date Feb 21, 2012
- Novartis AG
- Nicholas J Donato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for treatment of cell proliferative diseases
- Patent number 7,745,468
- Issue date Jun 29, 2010
- Board of Regents, University of Texas Systems The
- Waldemar Priebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of osteolytic lesions by SRC kinase inhibitors
- Patent number 7,468,379
- Issue date Dec 23, 2008
- The Board of Regents of the University of Texas System
- Bryant G. Darnay
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
DEUBIQUITINASE INHIBITORS AND METHODS FOR USE OF THE SAME
- Publication number 20160237082
- Publication date Aug 18, 2016
- The Regents of the University of Michigan
- Nicholas J. Donato
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Deubiquitinase Inhibitors and Methods for Use of the Same
- Publication number 20140357673
- Publication date Dec 4, 2014
- Nicholas J. Donato
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES
- Publication number 20140329901
- Publication date Nov 6, 2014
- Board of Regents, The University of Texas System
- Waldemar Priebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES
- Publication number 20120214850
- Publication date Aug 23, 2012
- Waldemar Priebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Deubiquitinase Inhibitors and Methods for Use of the Same
- Publication number 20120077806
- Publication date Mar 29, 2012
- The Regents of the University of Michigan
- Nicholas J. Donato
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES
- Publication number 20110021805
- Publication date Jan 27, 2011
- The Board of Regents of the University of Texas System
- Waldemar Priebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRYPHOSTIN-ANALOGS FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES
- Publication number 20100292229
- Publication date Nov 18, 2010
- The Board of Regents of the University of Texas System
- Nicholas J Donato
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF C-SRC INHIBITORS ALONE OR IN COMBINATION WITH STI571 FOR THE...
- Publication number 20090227608
- Publication date Sep 10, 2009
- Nicholas J. Donato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF C-SRC INHIBITORS ALONE OR IN COMBINATION WITH STI571 FOR THE...
- Publication number 20070149539
- Publication date Jun 28, 2007
- Nicholas J. Donato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of c-Src inhibitors alone or in combinaton with STI571 for the...
- Publication number 20070027167
- Publication date Feb 1, 2007
- Nicholas J. Donato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibition of osteolytic lesions by SRC kinase inhibitors
- Publication number 20070004748
- Publication date Jan 4, 2007
- The Board of Regents of the University of Texas System
- Bryant G. Darnay
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of c-Src inhibitors alone or in combination with STI571 for the...
- Publication number 20060074094
- Publication date Apr 6, 2006
- Nicholas J. Donato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for treatment of cell proliferative diseases
- Publication number 20050277680
- Publication date Dec 15, 2005
- Board of Regents, The University of Texas System
- Waldemar Priebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of c-src inhibitors alone or in combination with st1571 for the...
- Publication number 20040248906
- Publication date Dec 9, 2004
- Nicholas J Donato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Moshe Talpaz

Person

Patents Grantslast 30 patents

Deubiquitinase inhibitors and methods for use of the same

Compounds for treatment of cell proliferative diseases

Deubiquitinase inhibitors and methods for use of the same

Compounds for treatment of cell proliferative diseases

Use of c-Src inhibitors alone or in combination with STI571 for the...

Compounds for treatment of cell proliferative diseases

Use of c-Src inhibitors alone or in combination with STI571 for the...

Compounds for treatment of cell proliferative diseases

Inhibition of osteolytic lesions by SRC kinase inhibitors

Patents Applicationslast 30 patents

DEUBIQUITINASE INHIBITORS AND METHODS FOR USE OF THE SAME

Deubiquitinase Inhibitors and Methods for Use of the Same

COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES

COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES

Deubiquitinase Inhibitors and Methods for Use of the Same

COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES

TRYPHOSTIN-ANALOGS FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES

USE OF C-SRC INHIBITORS ALONE OR IN COMBINATION WITH STI571 FOR THE...

USE OF C-SRC INHIBITORS ALONE OR IN COMBINATION WITH STI571 FOR THE...

Use of c-Src inhibitors alone or in combinaton with STI571 for the...

Inhibition of osteolytic lesions by SRC kinase inhibitors

Use of c-Src inhibitors alone or in combination with STI571 for the...

Compounds for treatment of cell proliferative diseases

Use of c-src inhibitors alone or in combination with st1571 for the...